Topical Timolol for Superficial Infantile Hemangioma

Launched by MAHIDOL UNIVERSITY · Sep 11, 2012

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient who is less than 2 years
• • Patient who has been diagnosed with superficial infantile hemangioma
• • The tumor which has been in proliferative or plateau phase
• • There is no indication for systemic treatment
• • Informed consent is obtained from the parent of the patient
• Exclusion Criteria:
• • Patient who has the indication for systemic therapy
• • Patient who is treated by the other modality such as laser treatment
• • Patient who has underlying disease treated by beta blocker, corticosteroids, interferon, cyclophosphamide or vincristine
• • Patient who has history of hypersensitivity reaction to beta blocker, asthma, cardiac condition prove to heart block